58 studies found for:    apatinib
Show Display Options
Rank Status Study
1 Recruiting Effect of Rifampicin on the Pharmacokinetics of Apatinib
Condition: Neoplasms
Interventions: Drug: Apatinib Mesylate Tablets;   Drug: Rifampicin Capsules
2 Not yet recruiting ADjuVant Apatinib in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy
Condition: Nasopharyngeal Neoplasms
Interventions: Drug: Apatinib;   Drug: Placebo
3 Recruiting Apatinib for Metastatic Esophageal Cancer.
Conditions: Esophageal Cancer;   Metastatic Esophageal Cancer;   Apatinib
Intervention: Drug: Apatinib
4 Active, not recruiting The Study of Apatinib Plus CIK as the Third Line Therapy for Patients With Advanced Gastric Cancer
Condition: Stomach Neoplasms
Interventions: Biological: Cytokine-Induced Killer Cells;   Drug: Apatinib
5 Active, not recruiting The Study of Apatinib Plus CIK as the Third Line Therapy for Advanced Lung Adenocarcinoma Patients With Wild-Type EGFR
Condition: Adenocarcinoma of Lung
Interventions: Biological: Cytokine-Induced Killer Cells;   Drug: Apatinib
6 Recruiting Clinical Study of Apatinib and XELOX Combination Regimen to Treat Colorectal Cancer Patients
Condition: Colorectal Neoplasms
Intervention: Drug: Apatinib and XELOX combined treatment group
7 Recruiting Effect of Itraconazole on the Pharmacokinetics of Apatinib
Condition: Neoplasms
Interventions: Drug: Apatinib Mesylate Tablets;   Drug: Itraconazole Capsules
8 Recruiting A Study of Gefitinib With or Without Apatinib in Patients With Advanced Non-squamous Non-Small-Cell Lung Cancer Harboring EGFR Mutations
Condition: EGFR Tyrosine Kinase Inhibitors Plus VEGFR Inhibitors
Interventions: Drug: Apatinib;   Drug: Gefitinib;   Drug: Placebo
9 Recruiting Study of Apatinib in RET Fusion Positive Advanced Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Intervention: Drug: Apatinib single agent arm
10 Recruiting The Efficacy and Safety of Apatinib in Heavily Pretreated Advanced Non-squamous Non-small Cell Lung Cancer
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: apatinib single agent
11 Recruiting Apatinib and Irinotecan Combination Treatment in Esophageal Squamous Cell Carcinoma
Condition: Esophageal Squamous Cell Carcinoma
Interventions: Drug: Apatinib;   Drug: Irinotecan
12 Recruiting Apatinib as Maintenance Therapy After First Line Treatment in Locally Advanced or Metastatic Gastric Cancer
Condition: Gastric Cancer
Intervention: Drug: apatinib
13 Not yet recruiting A Study of Apatinib for Advanced Hepatocellular Carcinoma Patients After First-line Treatment Failure
Condition: Hepatocellular Carcinoma
Intervention: Drug: Apatinib Mesylate Tablets
14 Active, not recruiting Multicenter Phase II Study of Apatinib in Patients With Advanced Breast Cancer
Condition: Breast Cancer
Intervention: Drug: Apatinib
15 Recruiting Apatinib for Advanced Osteosarcoma After Failure of Standard Multimodal Therapy
Conditions: Osteosarcoma;   Metastasis
Intervention: Drug: apatinib
16 Completed A Study of Apatinib in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer
Condition: Non-Small-Cell Lung Cancer
Interventions: Drug: apatinib;   Drug: placebo
17 Not yet recruiting Apatinib as Second-line Treatment of Advanced Pancreatic Cancer
Condition: Pancreatic Neoplasms
Intervention: Drug: Apatinib
18 Recruiting Study of Apatinib in Metastatic Esophageal Cancer
Condition: Esophageal Cancer
Intervention: Drug: Apatinib
19 Recruiting The Efficacy and Safety of Apatinib Combined With Etoposide in Heavily Pretreated Advanced Non-small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer
Interventions: Drug: Apatinib;   Drug: Etoposide
20 Completed A Study of Apatinib in Non-triple-negative Metastatic Breast Cancer
Condition: Breast Neoplasms
Intervention: Drug: Apatinib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years